In phase 2 trials, orforglipron achieved up to 14.7% mean weight reduction at 36 weeks in adults with obesity or overweight, in line with the mid-teens weight reduction from NVOs higher dose oral semaglutide , as well as the injectables currently in the market
In the APOLLO-B trial (NCT03997383), which enrolled 360 patients with ATTR-CM, compared with placebo, patisiran treatment improved the 6-minute walk distance by 14.7 meters
Atherosclerosis involves more than just cholesterol
Individual timelines vary
What Experts Say About Tirzepatide and Breastfeeding Lets take a look at what some experts say about tirzepatide and breastfeeding: MotherToBaby: Their guidance says transfer into breast milk is unlikely, but because theres not enough human data, they recommend cautionespecially with newborns or preterm babies
Other Medications: Metformin users had marginally decreased risk, semaglutide users had unchanged risk, and dulaglutide and liraglutide users had an initially decreased risk which then increased